Skip to content
Home/Companies/Biotech/Topas Therapeutics
TT

Topas Therapeutics

Biotech·Germany·Active·9yr hold

Topas Therapeutics is a TMT company, headquartered in Germany.

Entry
2017
Hold
9yr
Status
Active
Est. EV
–

Who owns Topas Therapeutics?

Topas Therapeutics is currently owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage), since 2017. Across its history, Topas Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Boehringer Ingelheim Venture Fund
Most recent investor
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund · 2010 · Evergreen
2 ownership periods · full history below

Key facts

HQGermany
SectorTMT

Ownership history

2 ownership periods

Active
Co-held by Boehringer Ingelheim Venture Fund and Gimv since 2017.
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture FundActive
2017 · present · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
MOIC
–
Gimv
GimvActive
present · Gimv Portfolio
MOIC
–

More from Boehringer Ingelheim Venture Fund

Other portfolio companies in the same fund.

ProTgen
Active
BiotechUnited States· 2024
Refoxy Pharmaceuticals
Active
BiotechGermany· 2024
SwitchKine
Active
BiotechSwitzerland· 2024
Synthetica Pioneering
Active
BiotechChina· 2024
Aurobac Therapeutics
Active
BiotechFrance· 2023
Glox Therapeutics
Active
BiotechUnited Kingdom· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings